CELC Long Call Strategy
CELC (Celcuity Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
CELC (Celcuity Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $4.87B, a beta of 0.12 versus the broader market, a 52-week range of 12.48-151.02, average daily share volume of 1.3M, a public-listing history dating back to 2017, approximately 155 full-time employees. These structural characteristics shape how CELC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.12 indicates CELC has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long call on CELC?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current CELC snapshot
As of June 30, 2026, spot at $104.58, ATM IV 77.40%, IV rank 9.57%, expected move 22.19%. The long call on CELC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long call structure on CELC specifically: CELC IV at 77.40% is on the cheap side of its 1-year range, which favors premium-buying structures like a CELC long call, with a market-implied 1-standard-deviation move of approximately 22.19% (roughly $23.21 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CELC expiries trade a higher absolute premium for lower per-day decay. Position sizing on CELC should anchor to the underlying notional of $104.58 per share and to the trader's directional view on CELC stock.
CELC long call setup
The CELC long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CELC near $104.58, the first option leg uses a $105.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CELC chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CELC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $105.00 | $6.75 |
CELC long call risk and reward
- Net Premium / Debit
- -$675.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$675.00
- Breakeven(s)
- $111.75
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
CELC long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on CELC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$675.00 |
| $23.13 | -77.9% | -$675.00 |
| $46.25 | -55.8% | -$675.00 |
| $69.38 | -33.7% | -$675.00 |
| $92.50 | -11.6% | -$675.00 |
| $115.62 | +10.6% | +$387.06 |
| $138.74 | +32.7% | +$2,699.27 |
| $161.86 | +54.8% | +$5,011.48 |
| $184.99 | +76.9% | +$7,323.69 |
| $208.11 | +99.0% | +$9,635.90 |
When traders use long call on CELC
Long calls on CELC express a bullish thesis with defined risk; traders use them ahead of CELC catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
CELC thesis for this long call
The market-implied 1-standard-deviation range for CELC extends from approximately $81.37 on the downside to $127.79 on the upside. A CELC long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CELC IV rank near 9.57% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CELC at 77.40%. As a Healthcare name, CELC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CELC-specific events.
CELC long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CELC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CELC alongside the broader basket even when CELC-specific fundamentals are unchanged. Long-premium structures like a long call on CELC are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CELC chain quotes before placing a trade.
Frequently asked questions
- What is a long call on CELC?
- A long call on CELC is the long call strategy applied to CELC (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CELC stock trading near $104.58, the strikes shown on this page are snapped to the nearest listed CELC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CELC long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CELC long call priced from the end-of-day chain at a 30-day expiry (ATM IV 77.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$675.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CELC long call?
- The breakeven for the CELC long call priced on this page is roughly $111.75 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CELC market-implied 1-standard-deviation expected move is approximately 22.19%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on CELC?
- Long calls on CELC express a bullish thesis with defined risk; traders use them ahead of CELC catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current CELC implied volatility affect this long call?
- CELC ATM IV is at 77.40% with IV rank near 9.57%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.